Premium
‘Neuroendocrine’ differentiation in primary neoplasms of the liver
Author(s) -
Wang Jiahua,
Dhillon Amar P.,
Sankey Elizabeth A.,
Wightman A. Kay,
Lewin Jackie F.,
Scheuer Peter J.
Publication year - 1991
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.1711630111
Subject(s) - primary (astronomy) , neuroendocrine differentiation , pathology , medicine , biology , cancer , astronomy , physics , prostate cancer
Thirty primary liver neoplasms (16 hepatocellular, nine biliary, and five epithelioid haemangioendotheliomas) were studied for the expression of the general ‘neuroendocrine’ markers, neurone specific enolase (NSE) and protein gene product 9·5 (PGP 9·5). Grimelius silver staining for neurosecretory granules and immunostaining for S100 protein, HMB‐45, vasoactive intestinal polypeptide (VIP), and calcitonin were also performed. Eleven of the 16 hepatocellular carcinomas stained positively for PGP 9·5, four for NSE, six for HMB‐45, and two for S100 protein. Seven exhibited granular staining by the Grimelius method; eight showed immunostaining for VIP, and two for calcitonin. Three of the five haemangioendotheliomas demonstrated positive immunostaining for PGP 9·5, and two for NSE; of the nine biliary carcinomas, two showed staining for PGP 9·5 and NSE, and four contained cells staining with the Grimelius technique. Primary neoplasms of liver may show ‘neuroendocrine’ differentiation and this aspect of their phenotypic expression has to be considered before predicting the site of origin of a tumour in the liver.